aluates Reports

$ 0.0

Automative

Global Human Vaccination Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-11Q13363

Global Human Vaccination Market Research Report 2023

BUY CHAPTERS

Global Human Vaccination Market Research Report 2025

Code: QYRE-Auto-11Q13363

Report

January 2025

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Imbcams

Convac

NCPC

Bio Kangtai

Dynavax

Hissen

LG Life Sciences

Serum Institute

Pfizer Inc

KM Biologics

Human Vaccination Market Size

The global market for Human Vaccination was valued at US$ 59960 million in the year 2024 and is projected to reach a revised size of US$ 76800 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Human Vaccination Market

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Human Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccination.

The Human Vaccination market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Vaccination Market Report

Report Metric	Details
Report Name	Human Vaccination Market
Accounted market size in year	US$ 59960 million
Forecasted market size in 2031	US$ 76800 million
CAGR	3.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Inactivated Vaccine Live-attenuated Vaccine mRNA Vaccine Conjugate Vaccine Other
Segment by Application	Government Institution Private Sector Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, NCPC, Bio Kangtai, Dynavax, Hissen, LG Life Sciences, Serum Institute, Pfizer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Vaccination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Vaccination Market growing?

Ans: The Human Vaccination Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Human Vaccination Market size in 2031?

Ans: The Human Vaccination Market size in 2031 will be US$ 76800 million.

Who are the main players in the Human Vaccination Market report?

Ans: The main players in the Human Vaccination Market are GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, NCPC, Bio Kangtai, Dynavax, Hissen, LG Life Sciences, Serum Institute, Pfizer

What are the Application segmentation covered in the Human Vaccination Market report?

Ans: The Applications covered in the Human Vaccination Market report are Government Institution, Private Sector, Other

What are the Type segmentation covered in the Human Vaccination Market report?

Ans: The Types covered in the Human Vaccination Market report are Inactivated Vaccine, Live-attenuated Vaccine, mRNA Vaccine, Conjugate Vaccine, Other

Recommended Reports

Vaccine Technologies

Vaccine Market Segments

Vaccine Supply Chain

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Vaccination Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Inactivated Vaccine

1.2.3 Live-attenuated Vaccine

1.2.4 mRNA Vaccine

1.2.5 Conjugate Vaccine

1.2.6 Other

1.3 Market by Application

1.3.1 Global Human Vaccination Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Government Institution

1.3.3 Private Sector

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Vaccination Market Perspective (2020-2031)

2.2 Global Human Vaccination Growth Trends by Region

2.2.1 Global Human Vaccination Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Human Vaccination Historic Market Size by Region (2020-2025)

2.2.3 Human Vaccination Forecasted Market Size by Region (2026-2031)

2.3 Human Vaccination Market Dynamics

2.3.1 Human Vaccination Industry Trends

2.3.2 Human Vaccination Market Drivers

2.3.3 Human Vaccination Market Challenges

2.3.4 Human Vaccination Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Vaccination Players by Revenue

3.1.1 Global Top Human Vaccination Players by Revenue (2020-2025)

3.1.2 Global Human Vaccination Revenue Market Share by Players (2020-2025)

3.2 Global Human Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Human Vaccination Revenue

3.4 Global Human Vaccination Market Concentration Ratio

3.4.1 Global Human Vaccination Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Vaccination Revenue in 2024

3.5 Global Key Players of Human Vaccination Head office and Area Served

3.6 Global Key Players of Human Vaccination, Product and Application

3.7 Global Key Players of Human Vaccination, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Vaccination Breakdown Data by Type

4.1 Global Human Vaccination Historic Market Size by Type (2020-2025)

4.2 Global Human Vaccination Forecasted Market Size by Type (2026-2031)

5 Human Vaccination Breakdown Data by Application

5.1 Global Human Vaccination Historic Market Size by Application (2020-2025)

5.2 Global Human Vaccination Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Human Vaccination Market Size (2020-2031)

6.2 North America Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Human Vaccination Market Size by Country (2020-2025)

6.4 North America Human Vaccination Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Vaccination Market Size (2020-2031)

7.2 Europe Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Human Vaccination Market Size by Country (2020-2025)

7.4 Europe Human Vaccination Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Vaccination Market Size (2020-2031)

8.2 Asia-Pacific Human Vaccination Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Human Vaccination Market Size by Region (2020-2025)

8.4 Asia-Pacific Human Vaccination Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Vaccination Market Size (2020-2031)

9.2 Latin America Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Human Vaccination Market Size by Country (2020-2025)

9.4 Latin America Human Vaccination Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Vaccination Market Size (2020-2031)

10.2 Middle East & Africa Human Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Human Vaccination Market Size by Country (2020-2025)

10.4 Middle East & Africa Human Vaccination Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Human Vaccination Introduction

11.1.4 GSK Revenue in Human Vaccination Business (2020-2025)

11.1.5 GSK Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Human Vaccination Introduction

11.2.4 Merck Revenue in Human Vaccination Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Human Vaccination Introduction

11.3.4 Sanofi Revenue in Human Vaccination Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Sinovac

11.4.1 Sinovac Company Details

11.4.2 Sinovac Business Overview

11.4.3 Sinovac Human Vaccination Introduction

11.4.4 Sinovac Revenue in Human Vaccination Business (2020-2025)

11.4.5 Sinovac Recent Development

11.5 Zhejiang Pukang

11.5.1 Zhejiang Pukang Company Details

11.5.2 Zhejiang Pukang Business Overview

11.5.3 Zhejiang Pukang Human Vaccination Introduction

11.5.4 Zhejiang Pukang Revenue in Human Vaccination Business (2020-2025)

11.5.5 Zhejiang Pukang Recent Development

11.6 Changchun Institute of Biological

11.6.1 Changchun Institute of Biological Company Details

11.6.2 Changchun Institute of Biological Business Overview

11.6.3 Changchun Institute of Biological Human Vaccination Introduction

11.6.4 Changchun Institute of Biological Revenue in Human Vaccination Business (2020-2025)

11.6.5 Changchun Institute of Biological Recent Development

11.7 KM Biologics

11.7.1 KM Biologics Company Details

11.7.2 KM Biologics Business Overview

11.7.3 KM Biologics Human Vaccination Introduction

11.7.4 KM Biologics Revenue in Human Vaccination Business (2020-2025)

11.7.5 KM Biologics Recent Development

11.8 IMBCAMS

11.8.1 IMBCAMS Company Details

11.8.2 IMBCAMS Business Overview

11.8.3 IMBCAMS Human Vaccination Introduction

11.8.4 IMBCAMS Revenue in Human Vaccination Business (2020-2025)

11.8.5 IMBCAMS Recent Development

11.9 Convac

11.9.1 Convac Company Details

11.9.2 Convac Business Overview

11.9.3 Convac Human Vaccination Introduction

11.9.4 Convac Revenue in Human Vaccination Business (2020-2025)

11.9.5 Convac Recent Development

11.10 NCPC

11.10.1 NCPC Company Details

11.10.2 NCPC Business Overview

11.10.3 NCPC Human Vaccination Introduction

11.10.4 NCPC Revenue in Human Vaccination Business (2020-2025)

11.10.5 NCPC Recent Development

11.11 Bio Kangtai

11.11.1 Bio Kangtai Company Details

11.11.2 Bio Kangtai Business Overview

11.11.3 Bio Kangtai Human Vaccination Introduction

11.11.4 Bio Kangtai Revenue in Human Vaccination Business (2020-2025)

11.11.5 Bio Kangtai Recent Development

11.12 Dynavax

11.12.1 Dynavax Company Details

11.12.2 Dynavax Business Overview

11.12.3 Dynavax Human Vaccination Introduction

11.12.4 Dynavax Revenue in Human Vaccination Business (2020-2025)

11.12.5 Dynavax Recent Development

11.13 Hissen

11.13.1 Hissen Company Details

11.13.2 Hissen Business Overview

11.13.3 Hissen Human Vaccination Introduction

11.13.4 Hissen Revenue in Human Vaccination Business (2020-2025)

11.13.5 Hissen Recent Development

11.14 KM Biologics

11.14.1 KM Biologics Company Details

11.14.2 KM Biologics Business Overview

11.14.3 KM Biologics Human Vaccination Introduction

11.14.4 KM Biologics Revenue in Human Vaccination Business (2020-2025)

11.14.5 KM Biologics Recent Development

11.15 LG Life Sciences

11.15.1 LG Life Sciences Company Details

11.15.2 LG Life Sciences Business Overview

11.15.3 LG Life Sciences Human Vaccination Introduction

11.15.4 LG Life Sciences Revenue in Human Vaccination Business (2020-2025)

11.15.5 LG Life Sciences Recent Development

11.16 Serum Institute

11.16.1 Serum Institute Company Details

11.16.2 Serum Institute Business Overview

11.16.3 Serum Institute Human Vaccination Introduction

11.16.4 Serum Institute Revenue in Human Vaccination Business (2020-2025)

11.16.5 Serum Institute Recent Development

11.17 Pfizer

11.17.1 Pfizer Company Details

11.17.2 Pfizer Business Overview

11.17.3 Pfizer Human Vaccination Introduction

11.17.4 Pfizer Revenue in Human Vaccination Business (2020-2025)

11.17.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GSK

Merck

Sanofi

Sinovac

Zhejiang Pukang

Changchun Institute of Biological

Imbcams

Convac

NCPC

Bio Kangtai

Dynavax

Hissen

LG Life Sciences

Serum Institute

Pfizer Inc

KM Biologics

List of Tables

Table 1. Global Human Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Inactivated Vaccine

Table 3. Key Players of Live-attenuated Vaccine

Table 4. Key Players of mRNA Vaccine

Table 5. Key Players of Conjugate Vaccine

Table 6. Key Players of Other

Table 7. Global Human Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Human Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Human Vaccination Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Human Vaccination Market Share by Region (2020-2025)

Table 11. Global Human Vaccination Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Human Vaccination Market Share by Region (2026-2031)

Table 13. Human Vaccination Market Trends

Table 14. Human Vaccination Market Drivers

Table 15. Human Vaccination Market Challenges

Table 16. Human Vaccination Market Restraints

Table 17. Global Human Vaccination Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Human Vaccination Market Share by Players (2020-2025)

Table 19. Global Top Human Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccination as of 2024)

Table 20. Ranking of Global Top Human Vaccination Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Human Vaccination Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Human Vaccination, Headquarters and Area Served

Table 23. Global Key Players of Human Vaccination, Product and Application

Table 24. Global Key Players of Human Vaccination, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Human Vaccination Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Human Vaccination Revenue Market Share by Type (2020-2025)

Table 28. Global Human Vaccination Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Human Vaccination Revenue Market Share by Type (2026-2031)

Table 30. Global Human Vaccination Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Human Vaccination Revenue Market Share by Application (2020-2025)

Table 32. Global Human Vaccination Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Human Vaccination Revenue Market Share by Application (2026-2031)

Table 34. North America Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Human Vaccination Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Human Vaccination Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Human Vaccination Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Human Vaccination Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Human Vaccination Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Human Vaccination Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Human Vaccination Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Human Vaccination Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Human Vaccination Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Human Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Human Vaccination Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Human Vaccination Market Size by Country (2026-2031) & (US$ Million)

Table 49. GSK Company Details

Table 50. GSK Business Overview

Table 51. GSK Human Vaccination Product

Table 52. GSK Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 53. GSK Recent Development

Table 54. Merck Company Details

Table 55. Merck Business Overview

Table 56. Merck Human Vaccination Product

Table 57. Merck Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 58. Merck Recent Development

Table 59. Sanofi Company Details

Table 60. Sanofi Business Overview

Table 61. Sanofi Human Vaccination Product

Table 62. Sanofi Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 63. Sanofi Recent Development

Table 64. Sinovac Company Details

Table 65. Sinovac Business Overview

Table 66. Sinovac Human Vaccination Product

Table 67. Sinovac Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 68. Sinovac Recent Development

Table 69. Zhejiang Pukang Company Details

Table 70. Zhejiang Pukang Business Overview

Table 71. Zhejiang Pukang Human Vaccination Product

Table 72. Zhejiang Pukang Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 73. Zhejiang Pukang Recent Development

Table 74. Changchun Institute of Biological Company Details

Table 75. Changchun Institute of Biological Business Overview

Table 76. Changchun Institute of Biological Human Vaccination Product

Table 77. Changchun Institute of Biological Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 78. Changchun Institute of Biological Recent Development

Table 79. KM Biologics Company Details

Table 80. KM Biologics Business Overview

Table 81. KM Biologics Human Vaccination Product

Table 82. KM Biologics Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 83. KM Biologics Recent Development

Table 84. IMBCAMS Company Details

Table 85. IMBCAMS Business Overview

Table 86. IMBCAMS Human Vaccination Product

Table 87. IMBCAMS Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 88. IMBCAMS Recent Development

Table 89. Convac Company Details

Table 90. Convac Business Overview

Table 91. Convac Human Vaccination Product

Table 92. Convac Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 93. Convac Recent Development

Table 94. NCPC Company Details

Table 95. NCPC Business Overview

Table 96. NCPC Human Vaccination Product

Table 97. NCPC Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 98. NCPC Recent Development

Table 99. Bio Kangtai Company Details

Table 100. Bio Kangtai Business Overview

Table 101. Bio Kangtai Human Vaccination Product

Table 102. Bio Kangtai Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 103. Bio Kangtai Recent Development

Table 104. Dynavax Company Details

Table 105. Dynavax Business Overview

Table 106. Dynavax Human Vaccination Product

Table 107. Dynavax Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 108. Dynavax Recent Development

Table 109. Hissen Company Details

Table 110. Hissen Business Overview

Table 111. Hissen Human Vaccination Product

Table 112. Hissen Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 113. Hissen Recent Development

Table 114. KM Biologics Company Details

Table 115. KM Biologics Business Overview

Table 116. KM Biologics Human Vaccination Product

Table 117. KM Biologics Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 118. KM Biologics Recent Development

Table 119. LG Life Sciences Company Details

Table 120. LG Life Sciences Business Overview

Table 121. LG Life Sciences Human Vaccination Product

Table 122. LG Life Sciences Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 123. LG Life Sciences Recent Development

Table 124. Serum Institute Company Details

Table 125. Serum Institute Business Overview

Table 126. Serum Institute Human Vaccination Product

Table 127. Serum Institute Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 128. Serum Institute Recent Development

Table 129. Pfizer Company Details

Table 130. Pfizer Business Overview

Table 131. Pfizer Human Vaccination Product

Table 132. Pfizer Revenue in Human Vaccination Business (2020-2025) & (US$ Million)

Table 133. Pfizer Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Human Vaccination Picture

Figure 2. Global Human Vaccination Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Vaccination Market Share by Type: 2024 VS 2031

Figure 4. Inactivated Vaccine Features

Figure 5. Live-attenuated Vaccine Features

Figure 6. mRNA Vaccine Features

Figure 7. Conjugate Vaccine Features

Figure 8. Other Features

Figure 9. Global Human Vaccination Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Human Vaccination Market Share by Application: 2024 VS 2031

Figure 11. Government Institution Case Studies

Figure 12. Private Sector Case Studies

Figure 13. Other Case Studies

Figure 14. Human Vaccination Report Years Considered

Figure 15. Global Human Vaccination Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Human Vaccination Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Human Vaccination Market Share by Region: 2024 VS 2031

Figure 18. Global Human Vaccination Market Share by Players in 2024

Figure 19. Global Top Human Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccination as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Human Vaccination Revenue in 2024

Figure 21. North America Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Human Vaccination Market Share by Country (2020-2031)

Figure 23. United States Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Human Vaccination Market Share by Country (2020-2031)

Figure 27. Germany Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Human Vaccination Market Share by Region (2020-2031)

Figure 35. China Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Human Vaccination Market Share by Country (2020-2031)

Figure 43. Mexico Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Human Vaccination Market Share by Country (2020-2031)

Figure 47. Turkey Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Human Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. GSK Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 51. Merck Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 52. Sanofi Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 53. Sinovac Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 54. Zhejiang Pukang Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 55. Changchun Institute of Biological Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 56. KM Biologics Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 57. IMBCAMS Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 58. Convac Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 59. NCPC Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 60. Bio Kangtai Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 61. Dynavax Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 62. Hissen Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 63. KM Biologics Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 64. LG Life Sciences Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 65. Serum Institute Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 66. Pfizer Revenue Growth Rate in Human Vaccination Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Travelers Vaccines Market Research Report 2025

Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Dog Vaccines Market Insights Forecast to 2030

Global Cat Vaccines Market Insights Forecast to 2030

Global Veterinary Biological Vaccines Market Research Report 2025

Global Prophylactic Human Vaccine Market Research Report 2025

Global Biological Vaccines Adjuvants Market Research Report 2025

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Vaccination Market Research Report 2025

Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Vaccine Adjuvants Market

Animal Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Animal Vaccines Market Research Report 2024

Global Livestock Animal Vaccination Market Research Report 2025

Vaccine Include COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Vaccine Market

Global Viral Vector Vaccine for Humans Market Research Report 2024

Global Bacterial Vaccines for Humans Market Research Report 2024

Global Swine Vaccines Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions